Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6R-BH4 in poorly controlled hypertension
NCT00325962Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- May 2006
- Primary completion
- Dec 2006
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in hypertension (HTN), sponsored by BioMarin Pharmaceutical. Started May 2006; status: completed.
02
Drugs
sapropterin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00325962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325962.